Payment overview · 2025
General Payments
$850.83
10 reported records · 4 companies
Healthcare provider profile · identity verified
Ashutosh H Patel, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FESTUS, MO · NPI 1588735575
Verified facts
What the public records show
CMS Open Payments records show Ashutosh H Patel, MD received $850.83 in general payments during 2025 across 10 reported records.
Novo Nordisk Inc accounted for 43.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 143 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $367.51 | 43.2% | 3 | 2025 |
| Actelion Pharmaceuticals US, Inc. | Unresolved — no canonical attribution shown | $198.68 | 23.4% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $168.31 | 19.8% | 4 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $116.33 | 13.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $850.83 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $244.73 | 2 | 2025 |
Source payment records
|
|||||
| OPSUMIT Normalized: opsumit |
Drug | Actelion Pharmaceuticals US, Inc. | $198.68 | 2 | 2025 |
Source payment records
|
|||||
| UPTRAVI Normalized: uptravi |
Drug | Actelion Pharmaceuticals US, Inc. | $198.68 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $122.78 | 1 | 2025 |
Source payment records
|
|||||
| GLASSIA Normalized: glassia |
Biological | Takeda Pharmaceuticals U.S.A., Inc. | $116.33 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $29.15 | 3 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $23.05 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 143 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
143 | 22 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1421 | 296 |
| Levothyroxine Sodium | Levothyroxine Sodium | 989 | 126 |
| Lisinopril | Lisinopril | 815 | 148 |
| Amlodipine Besylate | Amlodipine Besylate | 724 | 164 |
| Omeprazole | Omeprazole | 567 | 110 |
| Metformin Hcl | Metformin Hcl | 561 | 108 |
| Metoprolol Tartrate | Metoprolol Tartrate | 455 | 78 |
| Pantoprazole Sodium | Pantoprazole Sodium | 446 | 89 |
| Tamsulosin Hcl | Tamsulosin Hcl | 414 | 74 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 411 | 96 |
| Losartan Potassium | Losartan Potassium | 398 | 92 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 381 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 377 | 81 |
| Gabapentin | Gabapentin | 334 | 78 |
| Hydrochlorothiazide | Hydrochlorothiazide | 287 | 51 |
| Eliquis | Apixaban | 285 | 44 |
| Furosemide | Furosemide | 284 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 271 | 48 |
| Quetiapine Fumarate | Quetiapine Fumarate | 255 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 245 | 68 |
| Fluoxetine Hcl | Fluoxetine Hcl | 243 | 58 |
| Lorazepam | Lorazepam | 221 | 45 |
| Tramadol Hcl | Tramadol Hcl | 221 | 36 |
| Mirtazapine | Mirtazapine | 214 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 203 | 32 |
| Alprazolam | Alprazolam | 199 | 33 |
| Levetiracetam | Levetiracetam | 194 | 22 |
| Montelukast Sodium | Montelukast Sodium | 194 | 28 |
| Simvastatin | Simvastatin | 193 | 34 |
| Irbesartan | Irbesartan | 192 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 185 | 52 |
| Propranolol Hcl | Propranolol Hcl | 179 | 17 |
| Potassium Chloride | Potassium Chloride | 178 | 37 |
| Sertraline Hcl | Sertraline Hcl | 177 | 45 |
| Allopurinol | Allopurinol | 175 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 174 | 41 |
| Famotidine | Famotidine | 167 | 24 |
| Chlorthalidone | Chlorthalidone | 166 | 33 |
| Alendronate Sodium | Alendronate Sodium | 162 | 37 |
| Meloxicam | Meloxicam | 162 | 31 |
| Trazodone Hcl | Trazodone Hcl | 162 | 36 |
| Warfarin Sodium | Warfarin Sodium | 162 | 13 |
| Memantine Hcl | Memantine Hcl | 161 | 11 |
| Xarelto | Rivaroxaban | 159 | 26 |
| Valsartan | Valsartan | 158 | 27 |
| Divalproex Sodium | Divalproex Sodium | 157 | 18 |
| Finasteride | Finasteride | 150 | 31 |
| Metformin Hcl Er | Metformin Hcl | 147 | 31 |
| Ozempic | Semaglutide | 143 | 22 |
| Pregabalin | Pregabalin | 141 | 24 |
| Jardiance | Empagliflozin | 126 | 20 |
| Naproxen | Naproxen | 123 | 38 |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 120 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 113 | 26 |
| Atenolol | Atenolol | 111 | 31 |
| Cephalexin | Cephalexin | 111 | 60 |
| Prednisone | Prednisone | 109 | 66 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 99 | 37 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 95 | 12 |
| Ibuprofen | Ibuprofen | 92 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 91 | suppressed |
| Spironolactone | Spironolactone | 89 | 31 |
| Entresto | Sacubitril/Valsartan | 88 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 86 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 83 | 21 |
| Olanzapine | Olanzapine | 83 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 82 | 28 |
| Lamotrigine | Lamotrigine | 78 | 12 |
| Baclofen | Baclofen | 76 | 20 |
| Buspirone Hcl | Buspirone Hcl | 76 | 22 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 76 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 74 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 74 | 11 |
| Donepezil Hcl | Donepezil Hcl | 71 | suppressed |
| Methotrexate | Methotrexate Sodium | 71 | suppressed |
| Azithromycin | Azithromycin | 70 | 56 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 69 | 16 |
| Carvedilol | Carvedilol | 66 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 66 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 65 | 49 |
| Lovastatin | Lovastatin | 64 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | 16 |
| Bupropion Xl | Bupropion Hcl | 60 | suppressed |
| Amoxicillin | Amoxicillin | 57 | 51 |
| Azelastine Hcl | Azelastine Hcl | 57 | 15 |
| Venlafaxine Hcl | Venlafaxine Hcl | 55 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 54 | suppressed |
| Nystatin | Nystatin | 54 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 14 |
| Bethanechol Chloride | Bethanechol Chloride | 52 | suppressed |
| Phenytoin | Phenytoin | 52 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 52 | suppressed |
| Clonazepam | Clonazepam | 51 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 51 | suppressed |
| Myrbetriq | Mirabegron | 50 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 49 | suppressed |
| Tiagabine Hcl | Tiagabine Hcl | 48 | suppressed |
| Torsemide | Torsemide | 48 | 13 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 46 | 12 |
| Carbamazepine Er | Carbamazepine | 45 | suppressed |
| Colchicine | Colchicine | 45 | 19 |
| Diazepam | Diazepam | 45 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 45 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 45 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 44 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 44 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 44 | 12 |
| Methylprednisolone | Methylprednisolone | 44 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 44 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 44 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 44 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 43 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 43 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | 11 |
| Gemfibrozil | Gemfibrozil | 42 | suppressed |
| Glimepiride | Glimepiride | 42 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 12 |
| Risperidone | Risperidone | 40 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | suppressed |
| Folic Acid | Folic Acid | 37 | 11 |
| Rybelsus | Semaglutide | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 31 |
| Metoclopramide Hcl | Metoclopramide Hcl | 36 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 36 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 36 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Carbamazepine | Carbamazepine | 34 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 33 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 24 |
| Dexamethasone | Dexamethasone | 30 | 12 |
| Meclizine Hcl | Meclizine Hcl | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Anastrozole | Anastrozole | 26 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Mupirocin | Mupirocin | 26 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 25 | 25 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Metronidazole | Metronidazole | 25 | 12 |
| Celecoxib | Celecoxib | 24 | suppressed |
| Ezetimibe | Ezetimibe | 24 | 11 |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Clotrimazole | Clotrimazole | 21 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 19 | suppressed |
| Erythromycin | Erythromycin Base | 19 | 17 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 19 | suppressed |
| Lubiprostone | Lubiprostone | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Mirabegron Er | Mirabegron | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 15 |
| Mesalamine | Mesalamine | 17 | suppressed |
| Phenobarbital | Phenobarbital | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 11 |
| Nitroglycerin | Nitroglycerin | 16 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 15 | suppressed |
| Paliperidone Er | Paliperidone | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 14 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 14 | suppressed |
| Zolmitriptan | Zolmitriptan | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 11 | 11 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $850.83 · 10 records | Novo Nordisk Inc | GLASSIA, OPSUMIT, OTEZLA, Ozempic, REPATHA, UPTRAVI, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error